Keyphrases
Multiple Sclerosis
100%
Endovascular Thrombectomy
96%
Cerebral Venous Sinus Thrombosis
80%
C-C Chemokine Receptor Type 5 (CCR5)
60%
Spinal Cord MRI
60%
Stroke Survivors
44%
Post-stroke Cognitive Impairment
42%
Protective Factors
40%
Cognitive Decline
40%
Maraviroc
40%
Post-stroke
35%
Ischemic Stroke
33%
Hemorrhagic Transformation
32%
Spinal Cord
31%
Tabasco
30%
Acute Ischemic Stroke
29%
Intravenous Thrombolysis
28%
Clinical Trials
28%
Cognitive Score
26%
Large Vessel Occlusion
26%
Post-stroke Depression
25%
Infarct Volume
25%
Intracerebral Hemorrhage
25%
Multiple Sclerosis Treatment
24%
Collateral Circulation
23%
Imaging Characteristics
22%
Cortical Infarcts
22%
Magnetic Resonance Imaging
22%
Spinal Cord Atrophy
21%
Cohort Analysis
20%
Multicenter Cohort Study
20%
X-linked Disorder
20%
Autoinflammatory Syndrome
20%
Ontario Canada
20%
Thyroid Antibodies
20%
Nonagenarians
20%
Doppler Ultrasonography
20%
E1 Enzyme
20%
Systemic Lupus Erythematous
20%
Coping Style
20%
Chronic Headache
20%
Antiepileptic Drugs
20%
Gait Impairment
20%
Bridge Treatment
20%
Vacuole
20%
Polymorphism
20%
Anterior Circulation
20%
Patient Characteristics
20%
African Ancestry
20%
Adult-onset
20%
Medicine and Dentistry
Apoplexy
87%
Cerebral Sinus Thrombosis
80%
Percutaneous Thrombectomy
76%
Brain Ischemia
53%
Cohort Analysis
46%
Maraviroc
40%
Protective Factor
40%
Infarction
30%
Magnetic Resonance Imaging
25%
Large Vessel Occlusion
25%
Cerebral Hemorrhage
25%
Post-Stroke Depression
23%
Collateral Circulation
23%
Blood Clot Lysis
21%
Depression
20%
Clinical Trial
20%
Multiple Sclerosis
20%
Somatics
20%
Vacuolization
20%
Echography
20%
Acoustic Shadow
20%
Janus Kinase
20%
Color Doppler Flowmetry
20%
Cognitive Defect
20%
Randomized Clinical Trial
20%
Posterior Communicating Artery
20%
Middle Cerebral Artery Occlusion
20%
Circle of Willis
20%
Carotid Artery
20%
Symptom
18%
National Institutes of Health Stroke Scale
15%
Loss of Function Mutation
13%
Adverse Event
12%
Computed Tomography Angiography
10%
Headache
10%
Montgomery-Åsberg Depression Rating Scale
10%
Cancer
10%
Cerebral Venous Sinus Thrombosis
9%
Hyperlipidemia
9%
Mortality Rate
9%
Recanalization
8%
Stenosis
8%
Multivariate Analysis
8%
Epileptic Absence
7%
Chemokine Receptor
6%
Prospective Study
6%
Transient Ischemic Attack
6%
Gamma Chemokine
6%
Venous Thromboembolism
6%
Anterior Cerebral Artery
6%
Neuroscience
Multiple Sclerosis
100%
Magnetic Resonance Imaging
98%
Brain Ischemia
74%
CCR5
43%
Cognitive Disorders
42%
Cerebral Venous Sinus Thrombosis
40%
Cerebral Hemorrhage
25%
Cerebrovascular Accident
24%
Alteplase
22%
Magnetic Resonance Imaging
22%
Brain Injury
20%
Anticonvulsant
20%
Headache
20%
Janus Kinase
20%
Ultrasonography
20%
Temporal Lobe Epilepsy
20%
Obstructive Sleep Apnea
20%
Systemic Lupus Erythematosus
20%
Doppler Ultrasonography
20%
Posttraumatic Stress Disorder
20%
Maraviroc
20%
Depression
20%
Brain Disease
20%
Collateral Circulation
20%
Meta-Analysis
20%
Stenosis
20%
Loss of Function Mutation
13%
Thyroid Antibody
13%
Magnetization Transfer
12%
Transient Ischemic Attack
11%
Fractional Anisotropy
10%
Placebo
10%
Hematoma
10%
Cerebrovascular Disease
8%
Expanded Disability Status Scale
7%
Angiography
7%
Gamma Chemokine
6%
Chemokine Receptor
6%
Diffusion Tensor Imaging
5%
Superior Sagittal Sinus
5%
Neurodegeneration
5%
